Latest Breaking News On - Johnt chang - Page 1 : comparemela.com

DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Kv1.3 Inhibitor for Immunological Diseases Including IBD and AD

/PRNewswire/ DP Technology, an "AI for Science" new paradigm-driven company, today announced the nomination of DPT0218, a novel small molecule targeting Kv1..

New research has major implications for controlling t cell activity: How a supposed 'nuclear' receptor makes TCR signaling possible

New LJI research has major implications for c

“Understanding the role of this receptor has such major implications for studying protective immunity, anticancer therapies, autoimmune disease, and neurological diseases."

Tissue-specific immunity may be the future: Research

Recent push to increase vaccine effectiveness has sparked numerous novel immunological findings, exposing numerous paradigms with unrealized therapeutic potenti

Study reveals a previously unappreciated complexity of TRM cell biology in the gut

Recent pressure to maximize vaccine efficacy has stirred up many new discoveries within immunology, revealing numerous paradigms with untapped therapeutic potential.